On November 16, Gelonghui Pharmaceutical (603811.SH) stated at the performance briefing that the company's EPA API uses both the Chinese and US declarations, and the US API DMF filing schedule is around the first half of next year. We are already in touch with our potential customers, and there are plans to expand the international market for fish oil pharmaceutical products.
诚意药业(603811.SH)：美国原料药DMF申报计划时间是明年上半年左右
Sincerity Pharmaceutical (603811.SH): The US API DMF filing schedule is around the first half of next year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.